Progression of cardiovascular damage: the role of renin-angiotensin system blockade

The American Journal of Cardiology
Jeffrey L Probstfield, Kevin D O'Brien

Abstract

The renin-angiotensin system (RAS) plays key roles throughout the cardiovascular continuum, and blockade of this system--either through angiotensin-converting enzyme (ACE) inhibition or through angiotensin II type 1 (AT(1)) receptor antagonism--now occupies a central place in the management of cardiovascular disease (CVD). Understanding of the RAS has expanded in recent years with the identification of new pathways for formation of angiotensin II and novel effector peptides, such as angiotensin-(1-7), which may constitute new therapeutic targets. A substantial proportion of the benefits of ACE inhibitors, including vasodilation, improvements in endothelial function, and inhibition of cell proliferation, appear to be attributable to decreases in angiotensin II and increases in bradykinin. In addition, however, there is evidence that other mechanisms, such as modulation of ACE signaling, may also contribute. Angiotensin receptor blockers (ARBs) selectively block AT(1) receptors and allow unopposed stimulation of AT(2) receptors, with potentially beneficial vasodilatory, anti-inflammatory, and antiproliferative effects. As a result, these agents share many of the clinical benefits of ACE inhibitors. Both ACE inhibitors and ARBs ha...Continue Reading

References

Jul 1, 1994·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·M SchartlU Hünten
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
May 3, 2002·Journal of the American College of Cardiology·Jawahar L Mehta, Dayuan Li
Sep 7, 2002·Hypertension·Tetsuya ShiuchiMasatsugu Horiuchi
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
May 27, 2003·Journal of Cellular Physiology·Erik J Henriksen, Stephan Jacob
Jun 24, 2003·The American Journal of Cardiology·Samy I McFarlaneJames R Sowers
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Sep 19, 2003·Lancet·K M Fox, UNKNOWN EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
Oct 29, 2003·Hypertension·Hongmei PengNour-Eddine Rhaleb
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Feb 27, 2004·Cardiovascular Research·Allan D Struthers, Thomas M MacDonald
Jul 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Dahai WangXiao-Ping Yang
Nov 27, 2004·BMJ : British Medical Journal·Subodh Verma, Marty Strauss
Jan 5, 2005·Hypertension·Stefan EngeliArya M Sharma
Jan 27, 2005·European Heart Journal·Lawrence S Zisman
Mar 18, 2005·Physiology·Ingrid FlemingRudi Busse
Jun 9, 2005·Hypertension·Ronald ClasenUlrich Kintscher
Apr 15, 2006·Circulation Research·Ingrid Fleming

❮ Previous
Next ❯

Citations

Oct 14, 2010·Current Diabetes Reports·Kunal ChaudharyAdam Whaley-Connell
Nov 20, 2012·Current Hypertension Reports·Jiandong Zhang, Steven D Crowley
Apr 27, 2012·International Journal of Peptides·Chris Tikellis, M C Thomas
Jul 10, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Tony AntoniouMuhammad M Mamdani
Feb 28, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ahmet AdiyamanArif Elvan
Sep 4, 2013·European Heart Journal·John G ClelandDarrel P Francis
Jun 22, 2013·Clinical and Experimental Hypertension : CHE·Johannes M van RooyenLeoné Malan
Aug 18, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·Vasiliki KatsiIoannis Kallikazaros
Jul 14, 2012·Kidney International·David M Charytan, John P Forman
Feb 5, 2010·The American Journal of Cardiology·Byron J Hoogwerf
Dec 3, 2013·European Journal of Clinical Investigation·Nathan ArtomAldo Pende
Aug 28, 2015·Biomacromolecules·Maomao YuRong Qi
Aug 15, 2014·British Journal of Pharmacology·S M KrishnanG R Drummond
Feb 19, 2014·Molecular Genetics and Metabolism·S M SirrsUNKNOWN CFDI investigators
Mar 5, 2013·International Journal of Cardiology·R Ferrari, G M Rosano
Apr 29, 2016·Journal of Human Hypertension·Y Y ChenH M Yu
Jun 4, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Michel E BertrandJean-Jacques Mourad
Oct 7, 2016·Journal of Toxicology and Environmental Health. Part a·Roger L Dos SantosMargareth R Moyses
Feb 5, 2011·American Journal of Hypertension·Dengfeng GaoGuanghua Hao
Apr 25, 2012·Therapeutic Advances in Cardiovascular Disease·Paolo VerdecchiaGianpaolo Reboldi
Oct 10, 2012·Therapeutic Advances in Cardiovascular Disease·Giancarla Aparecida Botelho-SantosRobson Augusto Souza Santos
Apr 24, 2014·Journal of the American Heart Association·Keyvan Karimi GalougahiGemma A Figtree
Nov 26, 2010·Current Opinion in Nephrology and Hypertension·Chris TikellisWendy C Burns
Sep 28, 2012·Clinical Science·Louise M BurrellSheila K Patel
Apr 4, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Jenifer M Brown, Anand Vaidya
Aug 15, 2014·Expert Review of Neurotherapeutics·Patrizia RipaSimona Sacco
Jul 1, 2016·Clinical Science·Bryna S M Chow, Terri J Allen
Jan 16, 2015·Journal of Cardiovascular Medicine·Claudio BorghiArrigo F G Cicero
Aug 16, 2017·International Journal of Endocrinology·Sarah ZaheerAnand Vaidya
Jun 12, 2013·Expert Review of Cardiovascular Therapy·Roberto Ferrari, Eric Boersma
Apr 23, 2020·Cardiovascular Drugs and Therapy·Michael GilletteHani Jneid
Nov 19, 2020·Clinical Science·Tatiane Cristine Silva de AlmeidaAna Cristina Simões E Silva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Related Papers

Nature Reviews. Drug Discovery
Mohammad Amin ZamanDavid Calhoun
Journal of the American College of Cardiology
Seth H GoldbargValentin Fuster
Hypertension Research : Official Journal of the Japanese Society of Hypertension
Yoshio IwashimaYuhei Kawano
© 2021 Meta ULC. All rights reserved